|
|
|
21.04.26 - 16:18
|
Trump wants $1.5tn for the Pentagon – and cuts to healthcare and housing | Steven Greenhouse (The Guardian)
|
|
|
The president's proposed $445bn increase in military spending would batter popular domestic programs as millions struggleWith Americans focused on Donald Trump's deeply unpopular war against Iran, far too few Americans are focusing on another disastrous Trump idea: increasing the Pentagon's budget to a colossal $1.5tn. Just as Trump's Iran war has hurt millions of Americans by sending gas prices skyward, Trump's supersized Pentagon budget will hurt millions of Americans because Trump, to help finance that budget, is pushing for painful cuts in health, education, and housing programs.By proposing a record-breaking $445bn increase in military spending, Trump is showing he's gung-ho for guns, but not for butter, even though millions of Americans are struggling financially and are eager for more butter – social spending – to make their lives easier. Trump's proposed military budget would mean a spectacular jump – it would be 42% above this year's budget and two-thirds bigger than Joe Biden's la...
|
|
|
21.04.26 - 14:45
|
Gerlach warnt vor Kliniksterben durch Krankenkassen-Reform (DPA-AFX)
|
|
|
MÜNCHEN (dpa-AFX) - Die Reformpläne von Bundesgesundheitsministerin Nina Warken (CDU) zur Krankenversicherung bedrohen laut Bayerns Gesundheitsministerin Judith Gerlach die Existenz von Krankenhäusern in einer nie dagewesenen Art und Weise. "Wenn die ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.04.26 - 14:57
|
Kassenärzte und Kliniken warnen vor schlechterer Versorgung (DPA-AFX)
|
|
|
BERLIN (dpa-AFX) - Kassenärzte und Klinikbranche warnen vor Verschlechterungen bei der Patientenversorgung durch die geplanten Milliarden-Einsparungen der Koalition für das Gesundheitswesen. "Eine Deckelung der Vergütung bedeutet natürlich Rationierung. ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18.04.26 - 05:00
|
As China′s biotech firms shift gears, can AI floor the accelerator? (SCMP)
|
|
|
A quarter featuring multiple eye-popping deals is no longer unusual for China's pharmaceutical industry – in fact, it may soon be considered a slow season.
In recent months, companies including CSPC Pharmaceutical and RemeGen have struck out-licensing agreements worth up to US$18.5 billion and US$5.6 billion respectively, while Haisco Pharmaceutical Group has added two of its own — most recently a deal worth up to US$745 million.
Under the terms of the deal, the Beijing-based Haisco granted US......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
